ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 917,96
-0,84%
Dow Jones
37 903,29
0,23%
DAX
17 926,69
0,03%
Brent Oil
84,075
0,64%
Bitcoin
57 797,05
-0,76%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Rafael Holdings Inc (RFL)

  7. Rafael Holdings Inc (RFL) Actualités

RFL

Rafael (RFL)

Rafael Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:RFL
DateHeureSourceTitreSymboleSociété
06/10/202112h30PR Newswire (US)Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical OfficerAMEX:RFLRafael Holdings Inc
17/09/202122h01PR Newswire (US)Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08AMEX:RFLRafael Holdings Inc
20/08/202113h00PR Newswire (US)Rafael Holdings Announces $104.2 Million Private PlacementAMEX:RFLRafael Holdings Inc
17/08/202116h11PR Newswire (US)Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics CompanyAMEX:RFLRafael Holdings Inc
30/06/202114h00GlobeNewswire Inc.Rafael Pharmaceuticals to Present Pancreatic & Biliary Tract Cancer Data on CPI-613® (Devimistat) from its Multicenter, Rand...AMEX:RFLRafael Holdings Inc
29/06/202117h00GlobeNewswire Inc.FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary CancerAMEX:RFLRafael Holdings Inc
23/06/202118h39PR Newswire (US)Rafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference ...AMEX:RFLRafael Holdings Inc
26/05/202115h00GlobeNewswire Inc.Rafael Pharmaceuticals to Present New Pancreatic Cancer and Biliary Tract Cancer Data featuring CPI-613® (Devimistat) at the...AMEX:RFLRafael Holdings Inc
30/03/202115h00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Enrollment of 150 Patients in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) fo...AMEX:RFLRafael Holdings Inc
19/01/202117h30GlobeNewswire Inc.Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor ConferenceAMEX:RFLRafael Holdings Inc
13/01/202115h00GlobeNewswire Inc.Rafael Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare ConferenceAMEX:RFLRafael Holdings Inc
22/12/202014h30PR Newswire (US)Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor P...AMEX:RFLRafael Holdings Inc
15/12/202017h09GlobeNewswire Inc.UPDATE - Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Mye...AMEX:RFLRafael Holdings Inc
15/12/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leuk...AMEX:RFLRafael Holdings Inc
01/12/202018h05GlobeNewswire Inc.Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimista...AMEX:RFLRafael Holdings Inc
10/11/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Pancreatic CancerAMEX:RFLRafael Holdings Inc
29/10/202014h30GlobeNewswire Inc.FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (devimistat) for Treatment of Soft Tissue SarcomaAMEX:RFLRafael Holdings Inc
27/10/202014h00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Enrollment of 100th Patient in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) f...AMEX:RFLRafael Holdings Inc
20/10/202015h00GlobeNewswire Inc.A New Phase 1 Study Began to Evaluate Rafael Pharmaceuticals’ Lead Compound CPI-613®️ (devimistat) for Patients With Pan...AMEX:RFLRafael Holdings Inc
24/08/202014h30PR Newswire (US)Rafael Holdings to Present at LD Micro Investor ConferenceAMEX:RFLRafael Holdings Inc
06/08/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals Achieves Target Enrollment of 500 Patients in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ®️ (de...AMEX:RFLRafael Holdings Inc
21/07/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Midpoint of Enrollment to First Interim Analysis in Pivotal Phase 3 Trial (ARMADA 2000) of CPI...AMEX:RFLRafael Holdings Inc
09/06/202023h28PR Newswire (US)Rafael Holdings Reports Third Quarter Fiscal Year 2020 ResultsAMEX:RFLRafael Holdings Inc
09/06/202023h25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RFLRafael Holdings Inc
09/06/202023h17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RFLRafael Holdings Inc
26/05/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals to Present Phase 1 Data on CPI-613® (Devimistat) in Patients with Locally Advanced or Metastatic Panc...AMEX:RFLRafael Holdings Inc
07/05/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals Announces In Vivo Study to Evaluate the Effects of CPI-613® (Devimistat) in Combination with Azacitid...AMEX:RFLRafael Holdings Inc
05/05/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals Enters into Research Collaboration with Roswell Park Comprehensive Cancer Center to Evaluate the Effec...AMEX:RFLRafael Holdings Inc
28/04/202015h00GlobeNewswire Inc.MD Anderson Cancer Center Now Enrolling Patients in Rafael Pharmaceuticals’ Phase 2 Clinical Trial of CPI-613® (devimistat...AMEX:RFLRafael Holdings Inc
23/04/202015h00GlobeNewswire Inc.Rafael Pharmaceuticals Receives Approvals to Open Trial Sites in India and Canada for Pivotal Phase 3 Trial (ARMADA 2000) of ...AMEX:RFLRafael Holdings Inc
 Showing the most relevant articles for your search:AMEX:RFL

Dernières Valeurs Consultées

USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
EU
GLE
Societe Generale
EU
ACA
Credit Agricole
EU
PX4
SBF 120
NASDAQ
AAPL
Apple
EU
BN
Danone
EU
PX1
CAC 40
NYSE
NKE
Nike
EU
ML
Michelin
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés